이는 유방암 같은 국지적 암 환자에게 효과가 있지만, 혈액암 환자 등에는 적합하지 않은 한계가 있다고 이 신문은 덧붙였다.
The paper added that it is effective for patients with localized cancers such as breast cancer, but it has limitations that are not suitable for patients with blood cancer.